Main > ONCOLOGY (**) > Lung>NSCLC>EGFR T790M+>MET > TREAT.: > Co: CN. H. Almonertinib Tablets>

---

Co: CN. H. Almonertinib Tablets>'s subsections
(*) CN Approval Date: 2020. 03.19.
>Progressed > EGFR TKI Therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 03.17.
PR Web-Site
TradeMark

Co: CN. H. Almonertinib Tablets>'s products
This section has no products